April 6, 2026
Unicorn or spamicorn?
The back story behind the first "$1.8B" dollar "AI Company"
One‑man AI miracle or spammy dropship clinic? The internet splits
TLDR: NYT crowned Medvi a one‑person, AI‑built $1.8B phenom; now a spam lawsuit and old exposés cloud the glow. Commenters are split between applauding a $60–70M hustle and calling it “dropshipping with doctors,” raising bigger questions about where AI innovation ends and aggressive marketing begins.
The internet went from high‑fiving to side‑eyeing in record time. After The New York Times hyped Medvi as a “one person, two months, $20K” AI wonder worth $1.8B, cheerleaders shouted “future of work!” and posted the now‑viral “solo CEO” meme. But within hours, receipts started flying: a lawyer flagged a fresh class action alleging spammy marketing, with claims of spoofed emails and sketchy subject lines (source). YouTubers resurrected an earlier Futurism exposé and accused the company of too‑good‑to‑be‑true before‑and‑afters and flimsy doctor pages. Suddenly, the hype thread became a “did we just stan a spam factory?” thread.
Not everyone’s buying the takedown. One commenter points out the Times says it saw financials and the founder has already cleared $60–70M, and that it’s not literally one guy—there were 10 contractors and a telehealth partner (OpenLoop). Fans call it scrappy hustle plus smart automation; skeptics say it’s “dropshipping with a stethoscope,” flipping demand for weight‑loss meds into cash with aggressive ads and affiliates. The jokes wrote themselves: “spamicorn,” “AI didn’t build it; affiliates did,” and “BS‑as‑a‑service.” The real fight here isn’t just Medvi—it’s the definition of an “AI company.” Is this a solo genius compressing a startup into weeks, or a marketing machine with legal headaches dressed up in AI glow? Either way, the comments are on fire.
Key Points
- •A New York Times article portrayed Medvi as a $1.8 billion “AI company,” and the story went viral as an AI success narrative.
- •Gary Marcus argues the NYT piece overlooked significant context about Medvi’s operations and marketing practices.
- •The article references a recent California class-action lawsuit alleging Medvi violated the state’s anti-spam law via affiliate marketing tactics.
- •Marcus cites a critical YouTube analysis and a May 2025 Futurism investigation into Medvi as important prior examinations.
- •The author contends the NYT should have engaged more deeply with these critiques to provide a fuller picture.